Denmark· DK-28107121724
Datroway
A datopotamab deruxtecan product containing datopotamab deruxtecan, registered in Denmark by Daiichi Sankyo Northern Europe GmbH. The same ATC class is registered in 9 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Datopotamab deruxtecan is registered in 9 of 19 countries.
Countries holding a registration under ATC L01FX35 (datopotamab deruxtecan), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 6 of them publish a price we can compare per daily dose
Datopotamab deruxtecan · ATC L01FX35
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Switzerlandprice
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Datopotamab deruxtecan
- Manufacturer
- Daiichi Sankyo Northern Europe GmbH
- Country
- Denmark (DK)
- ATC code
- L01FX35
- ATC class
- Datopotamab deruxtecan
- Defined daily dose
- 20 mg, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28107121724
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under L01FX35
Datopotamab deruxtecan, as other registers publish it.
- FinlandDatrowayDaiichi Sankyo Europe GmbH
- IcelandDatrowayDAIICHI SANKYO EUROPE GmbH*
- United StatesDATROWAYDaiichi Sankyo Inc.
- CzechiaDATROWAYDaiichi Sankyo Europe GmbH, Mnichov
- BelgiumDatroway 100 mgDaiichi Sankyo Europe
- NetherlandsDatroway 100 mg poeder voor concentraat voor oplossing voor infusieDAIICHI SANKYO EUROPE GmbH
- IrelandDatroway 100 mg powder for concentrate for solution for infusionDaiichi Sankyo Europe GmbH
- SwitzerlandDATROWAY 100 mg, Pulver für ein Konzentrat zur Herstellung einer InfusionslösungDaiichi Sankyo (Schweiz) AG
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/69f3a9bb-e49c-4f45-92e8-66ae74087f37 GET /v1/drugs/69f3a9bb-e49c-4f45-92e8-66ae74087f37?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "pulver til koncentrat til infusionsvæske, opløsning",
"source": "dkma",
"strength": "100 mg",
"auth_role": "RAP",
"dk_drugid": "28107121724",
"substance": "Datopotamab deruxtecan",
"auth_procedure": "Central",
"in_medicinpriser": false,
"registration_date_serial": "45751"
}See everything about datopotamab deruxtecan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.